Spasticity: etiology, evaluation, management, and the role of botulinum toxin type A
Gespeichert in:
Format: | Buch |
---|---|
Sprache: | English |
Veröffentlicht: |
New York, NY
Wiley
1997
|
Schriftenreihe: | Muscle & nerve / Supplement
6 |
Schlagworte: | |
Beschreibung: | 231 S. Ill., graph. Darst. |
Internformat
MARC
LEADER | 00000nam a2200000 cb4500 | ||
---|---|---|---|
001 | BV011723752 | ||
003 | DE-604 | ||
005 | 00000000000000.0 | ||
007 | t | ||
008 | 980120s1997 ad|| |||| 10||| eng d | ||
035 | |a (OCoLC)68059326 | ||
035 | |a (DE-599)BVBBV011723752 | ||
040 | |a DE-604 |b ger |e rakddb | ||
041 | 0 | |a eng | |
049 | |a DE-19 |a DE-355 |a DE-12 | ||
245 | 1 | 0 | |a Spasticity |b etiology, evaluation, management, and the role of botulinum toxin type A |c The Spasticity Study Group. Mitchell F. Brin, chairman and ed. |
264 | 1 | |a New York, NY |b Wiley |c 1997 | |
300 | |a 231 S. |b Ill., graph. Darst. | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
490 | 1 | |a Muscle & nerve / Supplement |v 6 | |
650 | 7 | |a Botuline |2 gtt | |
650 | 7 | |a Spasticiteit |2 gtt | |
650 | 0 | 7 | |a Spastizität |0 (DE-588)4198063-3 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Clostridium botulinum |0 (DE-588)4148089-2 |2 gnd |9 rswk-swf |
655 | 7 | |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |2 gnd-content | |
655 | 7 | |a Leermiddelen (vorm) |2 gtt | |
689 | 0 | 0 | |a Spastizität |0 (DE-588)4198063-3 |D s |
689 | 0 | 1 | |a Clostridium botulinum |0 (DE-588)4148089-2 |D s |
689 | 0 | |5 DE-604 | |
700 | 1 | |a Brin, Mitchell F. |e Sonstige |4 oth | |
710 | 2 | |a Spasticity Study Group |e Sonstige |0 (DE-588)5267769-2 |4 oth | |
810 | 2 | |a Supplement |t Muscle & nerve |v 6 |w (DE-604)BV010288172 |9 6 | |
999 | |a oai:aleph.bib-bvb.de:BVB01-007907241 |
Datensatz im Suchindex
_version_ | 1804126263082745856 |
---|---|
any_adam_object | |
building | Verbundindex |
bvnumber | BV011723752 |
ctrlnum | (OCoLC)68059326 (DE-599)BVBBV011723752 |
format | Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01467nam a2200397 cb4500</leader><controlfield tag="001">BV011723752</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">980120s1997 ad|| |||| 10||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)68059326</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV011723752</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-19</subfield><subfield code="a">DE-355</subfield><subfield code="a">DE-12</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Spasticity</subfield><subfield code="b">etiology, evaluation, management, and the role of botulinum toxin type A</subfield><subfield code="c">The Spasticity Study Group. Mitchell F. Brin, chairman and ed.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York, NY</subfield><subfield code="b">Wiley</subfield><subfield code="c">1997</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">231 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Muscle & nerve / Supplement</subfield><subfield code="v">6</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Botuline</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Spasticiteit</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Spastizität</subfield><subfield code="0">(DE-588)4198063-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Clostridium botulinum</subfield><subfield code="0">(DE-588)4148089-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="a">Leermiddelen (vorm)</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Spastizität</subfield><subfield code="0">(DE-588)4198063-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Clostridium botulinum</subfield><subfield code="0">(DE-588)4148089-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Brin, Mitchell F.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">Spasticity Study Group</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)5267769-2</subfield><subfield code="4">oth</subfield></datafield><datafield tag="810" ind1="2" ind2=" "><subfield code="a">Supplement</subfield><subfield code="t">Muscle & nerve</subfield><subfield code="v">6</subfield><subfield code="w">(DE-604)BV010288172</subfield><subfield code="9">6</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-007907241</subfield></datafield></record></collection> |
genre | (DE-588)4143413-4 Aufsatzsammlung gnd-content (DE-588)1071861417 Konferenzschrift gnd-content Leermiddelen (vorm) gtt |
genre_facet | Aufsatzsammlung Konferenzschrift Leermiddelen (vorm) |
id | DE-604.BV011723752 |
illustrated | Illustrated |
indexdate | 2024-07-09T18:14:40Z |
institution | BVB |
institution_GND | (DE-588)5267769-2 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-007907241 |
oclc_num | 68059326 |
open_access_boolean | |
owner | DE-19 DE-BY-UBM DE-355 DE-BY-UBR DE-12 |
owner_facet | DE-19 DE-BY-UBM DE-355 DE-BY-UBR DE-12 |
physical | 231 S. Ill., graph. Darst. |
publishDate | 1997 |
publishDateSearch | 1997 |
publishDateSort | 1997 |
publisher | Wiley |
record_format | marc |
series2 | Muscle & nerve / Supplement |
spelling | Spasticity etiology, evaluation, management, and the role of botulinum toxin type A The Spasticity Study Group. Mitchell F. Brin, chairman and ed. New York, NY Wiley 1997 231 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Muscle & nerve / Supplement 6 Botuline gtt Spasticiteit gtt Spastizität (DE-588)4198063-3 gnd rswk-swf Clostridium botulinum (DE-588)4148089-2 gnd rswk-swf (DE-588)4143413-4 Aufsatzsammlung gnd-content (DE-588)1071861417 Konferenzschrift gnd-content Leermiddelen (vorm) gtt Spastizität (DE-588)4198063-3 s Clostridium botulinum (DE-588)4148089-2 s DE-604 Brin, Mitchell F. Sonstige oth Spasticity Study Group Sonstige (DE-588)5267769-2 oth Supplement Muscle & nerve 6 (DE-604)BV010288172 6 |
spellingShingle | Spasticity etiology, evaluation, management, and the role of botulinum toxin type A Botuline gtt Spasticiteit gtt Spastizität (DE-588)4198063-3 gnd Clostridium botulinum (DE-588)4148089-2 gnd |
subject_GND | (DE-588)4198063-3 (DE-588)4148089-2 (DE-588)4143413-4 (DE-588)1071861417 |
title | Spasticity etiology, evaluation, management, and the role of botulinum toxin type A |
title_auth | Spasticity etiology, evaluation, management, and the role of botulinum toxin type A |
title_exact_search | Spasticity etiology, evaluation, management, and the role of botulinum toxin type A |
title_full | Spasticity etiology, evaluation, management, and the role of botulinum toxin type A The Spasticity Study Group. Mitchell F. Brin, chairman and ed. |
title_fullStr | Spasticity etiology, evaluation, management, and the role of botulinum toxin type A The Spasticity Study Group. Mitchell F. Brin, chairman and ed. |
title_full_unstemmed | Spasticity etiology, evaluation, management, and the role of botulinum toxin type A The Spasticity Study Group. Mitchell F. Brin, chairman and ed. |
title_short | Spasticity |
title_sort | spasticity etiology evaluation management and the role of botulinum toxin type a |
title_sub | etiology, evaluation, management, and the role of botulinum toxin type A |
topic | Botuline gtt Spasticiteit gtt Spastizität (DE-588)4198063-3 gnd Clostridium botulinum (DE-588)4148089-2 gnd |
topic_facet | Botuline Spasticiteit Spastizität Clostridium botulinum Aufsatzsammlung Konferenzschrift Leermiddelen (vorm) |
volume_link | (DE-604)BV010288172 |
work_keys_str_mv | AT brinmitchellf spasticityetiologyevaluationmanagementandtheroleofbotulinumtoxintypea AT spasticitystudygroup spasticityetiologyevaluationmanagementandtheroleofbotulinumtoxintypea |